Are inhaled corticosteroids a possible cause of Cushing's syndrome?
DOI:
https://doi.org/10.32818/reccmi.a9n3a6Keywords:
Cushing's syndrome, glucocorticoids, fluticasoneAbstract
Cushing's syndrome (CS) is an entity whose most frequent cause is the prolonged consumption of glucocorticoids,
either orally, topically or inhaled. Patients present very characteristic symptoms. Early identification is essential to reduce
the morbimortality caused by this disease. We present the case of a young asthmatic patient who, after 8 years
using inhaled fluticasone propionate (FP), debuted with exogenous CS.We present the case of a young asthmatic patient who, after eight years using inhaled fluticasone, debuts with an exogenous CS.
Downloads
Metrics
References
Cai Y, Ren L, Tan S, Liu X, Li C, Gang X, et al. Mechanism, diagnosis, and treatment
of cyclic Cushing’s syndrome: A review. Biomed Pharmacother 2022; 153: 113301.
doi: https://doi.org/10.1016/j.biopha.2022.113301 (último acceso oct. 2024).
Quddusi S, Browne P, Toivola B, Hirsch IB. Cushing syndrome due to surreptitious
glucocorticoid administration. Arch Intern Med 1998; 158(3): 294-296.
doi: https://doi.org/10.1001/archinte.158.3.294 (último acceso oct. 2024).
Lethielleux G, Bertherat J. Síndrome de Cushing. EMC - Tratado Med 2020;
(4): 1-9. doi: http://dx.doi.org/10.1016/S1636-5410(20)44310-7 (último
acceso oct. 2024).
Matos AC, Srirangalingam U, Barry T, Grossman AB. Cushing’s syndrome with
low levels of serum cortisol: the role of inhaled steroids. Clin Med (Lond).
; 11(4): 404-405. doi: http://dx.doi.org/10.7861/clinmedicine.11-4-404
(último acceso oct. 2024).
Paragliola RM, Papi G, Pontecorvi A, Corsello SM. Treatment with synthetic
glucocorticoids and the hypothalamus-pituitary-adrenal axis. Int J Mol Sci.
; 18(10): 2201-2218. doi: http://dx.doi.org/10.3390/ijms18102201 (último
acceso oct. 2024).
Joseph RM, Hunter AL, Ray DW, Dixon WG. Systemic glucocorticoid therapy
and adrenal insufficiency in adults: a systematic review. Semin Arthritis
Rheum. 2016; 46(1): 133-41. doi: http://dx.doi.org/10.1016/j.semarthrit.
03.001 (último acceso oct. 2024).
Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a
systematic review and meta-analysis. 1999. Database of Abstracts of Reviews
of Effects (DARE): Quality-assessed Reviews. York (UK): Centre for Reviews
and Dissemination (UK); 1995. Accesible en: https://www.ncbi.nlm.
nih.gov/books/NBK67970/ (último acceso oct. 2024).
Yasir M, Goyal A, Sonthalia S. Corticosteroid adverse effects. StatPearls. Treasure
Island (FL): StatPearls Publishing; 2024. Accesible en: https://www.ncbi.
nlm.nih.gov/books/NBK531462/ (último acceso oct. 2024).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ana Prieto-Álvarez, José Manuel Machín-Lázaro, Raúl Piedra-Castro, María Blanco-Crespo
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
